前列消癥汤联合内分泌疗法治疗D期前列腺癌的临床观察
|
摘要
目的:研究前列消癥汤对前列腺癌的治疗作用。
方法:近些年来我科采取中西医结合的方法治疗前列腺癌,即在常规西药治疗同时口服前列消癥汤加减方,每剂浓煎300mL,早晚各口服150ml。前列消癥汤是刘猷枋教授应用现代医学结合中医药传统理论,根据多年临床经验总结而成,该方由生薏米,炙黄芪,黄精,白花蛇舌草,土贝母,莪术,猪苓组成,方中以生薏米健脾渗湿为君药,炙黄芪、黄精补气健脾养阴,白花蛇舌草解毒软坚为臣药,伍以莪术、土贝母、猪苓解毒散结、祛瘀止痛,如此配伍,共达补益气血、清热解毒利湿之功,体现了中医扶正祛邪的原则。实验研究已经证实生薏米中的不饱和脂肪酸有抗肿瘤作用,同时也是有效的抗肿瘤促进剂;黄芪和黄精均有免疫调节作用,能提高细胞免疫、体液免疫、补体水平,对免疫抑制有一定对抗作用;此外黄芪还有抗肿瘤作用,其有效成分黄芪多糖对淋巴细胞激活有增效作用,能增强人体外周血单个核细胞产生肿瘤坏死因子,增强LNK细胞细胞毒作用等;白花蛇舌草中的白花蛇舌草素,土贝母中的土贝母糖甙,猪苓中的猪苓酮,莪术中的萜类成分榄香烯和莪术醇均具有抗肿瘤作用。
本课题选取首次发现前列腺癌患者20例,将其均衡的分为治疗组和对照组两组,治疗组采用内分泌治疗联合前列消癥汤加减方治疗,对照组单纯用内分泌治疗。治疗6个月后,通过观察两组生存质量量化评分表(欧洲肿瘤研究与治疗组织(EORTC)制定的前列腺癌患者生存质量量表),中医症状记分,血清PSA变化,并通过观察两组治疗前后的血、尿,便及肝肾功能,心电图结果来记录可能的不良反应。应用统计软件SPSS11.0,计量资料治疗前后的变化采用自身配对的t检验(正态分布时);不服从正态分布时,采用轶和检验P<0.05为差异有显著性意义,所有的统计检验均为双侧概率检验。
结果:从本次研究的结果可以看出,治疗6月后患者排尿不畅,或尿频尿急,尿痛血尿,体力状况,骨痛,血清PSA均不同程度得到改善,但治疗组优于对照组。同时与对照组相比,治疗组很少出现烘热汗出,头晕,疲劳乏力、食欲不振、便秘、失眠及情绪变化。
结论:前列消癥汤联合内分泌治疗可显著改善前列腺癌患者的临床症状,降低血清PSA,提高患者的生存质量。
Objective: to research the therapeutic action of Qianlie Xiaozheng Tang (QXT, Decoction of Softening Hard-mass in Prostate ) on PCA
Methods: During these years we treated PCA patients with the method of combining TCM and bio-medicine. That is to say, we gave patients QXT while they were recieving routine bio-medical therapy. QXT was cooked into 300ml of each dose, 150ml po M ev N. Applying the result of modern science reseach and the theory of traditional Chinese medicine, Professor Liu Youfang made up QXT with his clinical experiences over years. QXT is composed by Yimi (raw), Fhuangqi (parched), Huangjing, Sheshecao (write-flowered), Tubeimu, Ezhu, Zhuling. Yimi with the function of strengthening the spleen and eliminating damp is the monarch drug of the decoction; Huangqi and Huangjing with the function of invigorating qi, strengthening the spleen and enriching yin combinining with Sheshecao functioning of detoxication and softening hard masses is the ministerial drugs; with the help of Tubeimu, Ezhu, Zhuling, this formulae has the action of benefiting qi & blood, clearing heat, detoxicating, and eliminating damp, which shows the TCM principle ---- supporting healthy energy to eliminate evils. It has been proved in the expirical study that unsaturated fatty acid contained in Yimi has the function of anti-tumor and anti-tumor-promoter. Huangqi and Huangjing can regulate immunization; besides, Huangqi also has the function of anti-tumor.Oldenlandin in Sheshecao,bolbostemmae,rhizoma Glycoside in Tubeimu, Polyporus ketone in Zhuling,and Terpene of elemene & curcumenol in Ezhu all have the function of anti-tumor.
20 consecutive patients were included in our study who were first-time diagnosed as PCA on State-D and put into two groups in equilibration: the therapeutic group and the control group. Patients in the therapeutic group accepted the hormonal therapy combined with QXT, while in the control group patients received the hormonal therapy singly. After 6-month treatments, through observation on EORTC QLQ of two groups, scoring of TCM symptoms, changing of serum PsA, blood, excrement and urine routine before and after the treatments, hepar & renal function, and ECG we evaluated the therapeutic effect and recorded the possible untoward effects, and analyzed the data with the statistic software SPSS11.0.
Results: After 6-month treatments, the clinical symptoms and signs (unsmooth urination, frequent & urgent maturation, physical strength, etc.), and the status of serum PsA are all improved on different levels, the therapeutic group being improved better than the control group. At the same time, comparing with ones in the control group, patients in the therapeutic group are less getting tidal fever, sweating, dizziness, acratia, poor appetite, constipation, insomnia, and mood change.
Conclusions: QXT significantly improved the clinical symptoms and sighs of the Stage-D PCA patients who are receiving the hormonal therapy, decreased the serum PsA, and raised the level of QoL (Quality of Life).
方法:近些年来我科采取中西医结合的方法治疗前列腺癌,即在常规西药治疗同时口服前列消癥汤加减方,每剂浓煎300mL,早晚各口服150ml。前列消癥汤是刘猷枋教授应用现代医学结合中医药传统理论,根据多年临床经验总结而成,该方由生薏米,炙黄芪,黄精,白花蛇舌草,土贝母,莪术,猪苓组成,方中以生薏米健脾渗湿为君药,炙黄芪、黄精补气健脾养阴,白花蛇舌草解毒软坚为臣药,伍以莪术、土贝母、猪苓解毒散结、祛瘀止痛,如此配伍,共达补益气血、清热解毒利湿之功,体现了中医扶正祛邪的原则。实验研究已经证实生薏米中的不饱和脂肪酸有抗肿瘤作用,同时也是有效的抗肿瘤促进剂;黄芪和黄精均有免疫调节作用,能提高细胞免疫、体液免疫、补体水平,对免疫抑制有一定对抗作用;此外黄芪还有抗肿瘤作用,其有效成分黄芪多糖对淋巴细胞激活有增效作用,能增强人体外周血单个核细胞产生肿瘤坏死因子,增强LNK细胞细胞毒作用等;白花蛇舌草中的白花蛇舌草素,土贝母中的土贝母糖甙,猪苓中的猪苓酮,莪术中的萜类成分榄香烯和莪术醇均具有抗肿瘤作用。
本课题选取首次发现前列腺癌患者20例,将其均衡的分为治疗组和对照组两组,治疗组采用内分泌治疗联合前列消癥汤加减方治疗,对照组单纯用内分泌治疗。治疗6个月后,通过观察两组生存质量量化评分表(欧洲肿瘤研究与治疗组织(EORTC)制定的前列腺癌患者生存质量量表),中医症状记分,血清PSA变化,并通过观察两组治疗前后的血、尿,便及肝肾功能,心电图结果来记录可能的不良反应。应用统计软件SPSS11.0,计量资料治疗前后的变化采用自身配对的t检验(正态分布时);不服从正态分布时,采用轶和检验P<0.05为差异有显著性意义,所有的统计检验均为双侧概率检验。
结果:从本次研究的结果可以看出,治疗6月后患者排尿不畅,或尿频尿急,尿痛血尿,体力状况,骨痛,血清PSA均不同程度得到改善,但治疗组优于对照组。同时与对照组相比,治疗组很少出现烘热汗出,头晕,疲劳乏力、食欲不振、便秘、失眠及情绪变化。
结论:前列消癥汤联合内分泌治疗可显著改善前列腺癌患者的临床症状,降低血清PSA,提高患者的生存质量。
Objective: to research the therapeutic action of Qianlie Xiaozheng Tang (QXT, Decoction of Softening Hard-mass in Prostate ) on PCA
Methods: During these years we treated PCA patients with the method of combining TCM and bio-medicine. That is to say, we gave patients QXT while they were recieving routine bio-medical therapy. QXT was cooked into 300ml of each dose, 150ml po M ev N. Applying the result of modern science reseach and the theory of traditional Chinese medicine, Professor Liu Youfang made up QXT with his clinical experiences over years. QXT is composed by Yimi (raw), Fhuangqi (parched), Huangjing, Sheshecao (write-flowered), Tubeimu, Ezhu, Zhuling. Yimi with the function of strengthening the spleen and eliminating damp is the monarch drug of the decoction; Huangqi and Huangjing with the function of invigorating qi, strengthening the spleen and enriching yin combinining with Sheshecao functioning of detoxication and softening hard masses is the ministerial drugs; with the help of Tubeimu, Ezhu, Zhuling, this formulae has the action of benefiting qi & blood, clearing heat, detoxicating, and eliminating damp, which shows the TCM principle ---- supporting healthy energy to eliminate evils. It has been proved in the expirical study that unsaturated fatty acid contained in Yimi has the function of anti-tumor and anti-tumor-promoter. Huangqi and Huangjing can regulate immunization; besides, Huangqi also has the function of anti-tumor.Oldenlandin in Sheshecao,bolbostemmae,rhizoma Glycoside in Tubeimu, Polyporus ketone in Zhuling,and Terpene of elemene & curcumenol in Ezhu all have the function of anti-tumor.
20 consecutive patients were included in our study who were first-time diagnosed as PCA on State-D and put into two groups in equilibration: the therapeutic group and the control group. Patients in the therapeutic group accepted the hormonal therapy combined with QXT, while in the control group patients received the hormonal therapy singly. After 6-month treatments, through observation on EORTC QLQ of two groups, scoring of TCM symptoms, changing of serum PsA, blood, excrement and urine routine before and after the treatments, hepar & renal function, and ECG we evaluated the therapeutic effect and recorded the possible untoward effects, and analyzed the data with the statistic software SPSS11.0.
Results: After 6-month treatments, the clinical symptoms and signs (unsmooth urination, frequent & urgent maturation, physical strength, etc.), and the status of serum PsA are all improved on different levels, the therapeutic group being improved better than the control group. At the same time, comparing with ones in the control group, patients in the therapeutic group are less getting tidal fever, sweating, dizziness, acratia, poor appetite, constipation, insomnia, and mood change.
Conclusions: QXT significantly improved the clinical symptoms and sighs of the Stage-D PCA patients who are receiving the hormonal therapy, decreased the serum PsA, and raised the level of QoL (Quality of Life).
引文
[1]Jemal A,Murray T,Samueles A, et、al. Cancer Statistics. CA Cancer[J]. Clin, 2003,53,5-26
[2] 丁永锋,张亚大,朱子军,张文林,邹传兵.77例前列腺癌中医证型特点与临床相关因素分析[J].中国中西医结合外科杂志2006, l(6):529
[3]吕立国,古炽明,王昭辉,代睿欣,潘明沃,范燕兰.陈志强教授对晚期前列腺癌中医病因病机的探讨[J].新中医,2007,39(2):81
[4]李曰庆主编,实用中西医结合泌尿男科学,第一版,北京:人民卫生出版社:186-190
[5]吴阶平马永江主编,实用泌尿外科学,第 1 版,北京:人民军医卫生出版社:258
[6]陈孝平主编,外科学,第 1 版,北京:人民卫生出版社:874-875
[7]仇成轩,施侣元,张惠娟.饮食与前列腺癌危险性关系的病例对照研究[J].中国慢性病预防与控制,2001, 9 (2) :75
[8]吴阶平马永江主编,实用泌尿外科学,第 1 版,北京:人民军医卫生出版社:259
[9]张惠娟,仇成轩,施侣元,刘小强,周宇凡.前列腺癌危险因素配比病例对照研究[ J].预防医学情报杂志,1999,15(1):9
[10]董志伟谷铣之主编,临床肿瘤学,第 1 版,北京:人民卫生出版社:1135-1149
[11]陈伟,李澄棣.治疗前列腺癌的中草药 PC-SPES[J].中华泌尿外科杂志,2002, 23( 6):378-379
[12] Small EJ, Frohl ich MW BokRet al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. [J] Clin Oncol, 2000, 18(21):3595
[13] Pirani JF.The effects of phytot herapeutic agents on prostate cancer:an overview of recent clinical trials of PC-SPES. Urology,2001,58(2suppl 1):36
[14]钟亮,赖海标,黄智峰,曾哗,赖伟业,伍伟超.中西医结合治疗晚期前列腺癌疗效观察[ J].现代中西医结合杂志,2005,14(4):480
[15]古炽明,吕立国,王昭辉,陈志强.中西医结合治疗前列腺癌的临床观察[J]. 广东药学院学报,2007,23(1):93
[16]张亚强,林 飞,刘猷枋.前列消癥汤治疗前列腺癌的临床观察[J] 中国中西医结合外科杂志,2006,12(2):83
[17]张秉鸿,,王庆堂,王 亮,南勋义.中药鸦胆子对前列腺癌细胞超微结构及 PSA水平的影响[J].西南国防医药,2007,17(4):402
[18]陈 铭,高松占,甄波.消瘀散结灌肠剂治疗晚期前列腺癌 18 例[J].甘肃中医,2007,20(7):42
[19] 吴自强. 中医外治学术研究近况[J].中医外治杂志,1992,2(3):40
[20]彭煜,培初.泉安方治疗晚期前列腺癌骨转移痛初探[J].中国男科学杂志,2004,18(4):47
[21]李广诚,曾江正. 补肾壮骨中药合博宁治疗骨转移癌 15 例[J].湖南中医杂志,2007,23(2):52
[22] 黄 立 中 , 莫 新 民 . 骨 转 移 瘤 的 中 医 病 机 认 识 与 治 疗 [J]. 湖 南 中 医 药 导报,1997,3(2-3):5
[23]刘临兰.阳和汤治疗骨转移疼痛 32 例.新中医,1994,(9):51
[24]黄立中,蒋益兰,曾松林,等.阳和汤加味治疗骨转移癌疼痛 63 例.湖南中医学院学报,1997,17(1):20
[25] 郑 翠 娥 , 王 晓 红 , 胡 晓 辉 . 阳 和 汤 加 减 治 疗 骨 肿 瘤 . 山 东 中 医 杂志,1998,17(2):62
[26]张剑.李辅仁治疗前列腺癌睾丸摘除术后诸症的经验[J].中医杂志,1998, 39( 2):83
[27]Hammar M Frisk J,Grimas
,et al. Acupuncture treatment of vasomotor symptoms in man with prostatic carcinoma: a pilot study.J Urol,1999, 161(3):853
[28]侯成饮,陈素嫣.扶正除湿饮治疗晚期前列腺癌 5 例疗效观察[J].山东中医杂志,1996, 15(增刊): 28
[29] Darzynkiew icz Z, Traganos F,Wu,JM,et al. Chinese herbal mixture PC-SPES in treatment of prostate cancer[J].Int J Oncol, 2000, 17: 729
[30]杜广,张正望,张永康,郭剑明. 中药制剂 PC-SPESⅡ对前列腺癌激素非依赖型细胞株 PC-3 诱导凋亡的作用[J]. 中华男科学杂志,2007,13(6):566
[31]Odakak,T Y.Indentification of antimicrobial and an tioxidant constitutes from licorice of Russia and X injiang origin[J].Chem Pham Bu[J]1987,37(9):25-28
[32]FujisawaY,SakamotoM,MatsushitaM,et lGlycyrrhizin inhibits the lytic pathway ofcomplement-possible mechanism of its anti-inflammatory effect on liver ells in viral hepatitis[J].Microbiolmmunol,2000,44 (9):799--804
[33] 王英俊,刘方州,侯勇谋.甘草甜素诱导前列腺癌细胞株 DU 145 凋亡的体外研究[J]. 中华男科学杂志,2007,4(11):146
[34]Ray KD,Mendulis LM,Gurule MW,et al Ca2+ antagonistsin- hib it DNA fragmentation and toxic cell death induced by acetam fragmentation and toxic cell death induced by acetam inophen[J]. FASE-BJ,1999, 7(5):453.
[35]Burlch W , Lauer B, T immermann -Trosier, et al Con trolled death apopto-sis) of nomal and putativepreneo plastic cells in rat liver following withdrawal of tumorprrmoters[J].Carcinogenesis, 2001, 5(4):5.
[36] 王小芹,杨静,郑航.异甘草素脂质体对人前列腺癌细胞体外增殖的抑制作用[J]. 医学新知杂志,2007,17(2):85
[37] 张瑞,张鹏宇,郭军,杨冬,王文杰,郑美华,马艳春.雷公藤内酯醇对小鼠前列腺癌细胞株 RM-1 的影响[J].中华男科学杂志,2007,13(3):237.
[38] 罗钰填,余建华,邓刚,叶章群.雷公藤内酯醇对前列腺癌细胞 P C- 3 及血管内皮生长因子的影响临床[J].泌尿外科杂志,2007,22(4):289
[39]郑敏,梅贤巨,鲍翠玉.大蒜多糖体体外抗柯萨奇病毒 B-3 作用[J]中国现代应用药学杂志,2005,22 (1): 4-6
[40]Agarwal C,Singh RP,Agarwal R G rape seed extract induces apoptotic death of human prostate carcinoma DL-145 cells viacaspases activation accompanied by dissipation of m itochondrial membrane potentia1 and cytochrom e c re lease[J].Carcinogenesis,2002,23 (11): 1869-76
[41]孙怡,商学军,葛京平,等.原花青素对前列腺癌 PC-3 细胞增殖和凋亡的影响[J].山东医药,2006,46(6): 12-4
[42]吴自勍，黄浩，丁雪梅，罗荣城.原花青素对前列腺癌 LNCaP 细胞增殖和凋亡的影响[J].南方医药大学学报,2007 ;27(4):499
[43]张维东,崔亚洲,武利存,等.蝎毒多肽提取物的抗血管生成作用[J].细胞生物学杂志,2005, 27( 3) : 343- 346
[44] 张月英,张维东,贾青,王兆朋,黄山英,宋守琴,王朝霞.蝎毒多肽提取物抑制 DU - 145 细胞,COX- 2 和 MMP- 9 表达的研究[J].现代生物医学进展,2006, 6 N0.5:10
[45] Ogasawara M, Matsubara T,Suzuki H. Screening of natural compounds for inhibitory activity on colon cancer cell migration [J].Biol Pham Bull,2001,24(6): 720-3.
[46]张莹,张起辉,吴立军,等.吴茱萸碱诱导人宫颈癌 Hela 细胞调亡过程中非caspase 调控因素[J].中国药理学通报,2004,20( 1): 61-4.
[47] 张辉,吕家驹,丁森泰,张捷,赵跃然.吴茱萸碱诱导前列腺癌 PC-3 细胞凋亡机制的实验研究[J].中国老年学杂志,2007,27:1231
[48]栾连军,王叶飞,张琳,吴永江.藤苦参素的体外抗肿瘤活性及其对癌细胞凋亡的作用[J].药学学报,2007, 42( 1): 104- 107
[49]丁新民,保庭毅,杨增悦,邱建新,巨生产.二氧化二砷对前列腺癌 PC -3 细胞周期调节分子的影响[J].医学研究生学报,2006,19(6):501
[50]Kinoshita H,Shi Y,Sandefur C,et al.Methylation receptor minimal promoter silences transcription in human prostate cancer [J].Cancer Res,2000,60(13):3623-3630
[51] 李小民.樊青霞.赵培荣.王瑞林.王留兴.三氧化二砷重新激活 PC- 3 前列腺癌细胞雄激素受体基因的表达.肿瘤基础与临床,2006,19(4):295
[52]厉将斌,王沛,那彦群,郭应禄.前列腺癌中医药治疗的经验与思路.中国中西医结合杂志,2002, 22(6):425 [51] 李小民.樊青霞.赵培荣.王瑞林.王留兴.三氧化二砷重新激活 PC- 3 前列腺癌细胞雄激素受体基因的表达.肿瘤基础与临床,2006,19(4):295 [52]厉将斌,王沛,那彦群,郭应禄.前列腺癌中医药治疗的经验与思路.中国中西
[2] 丁永锋,张亚大,朱子军,张文林,邹传兵.77例前列腺癌中医证型特点与临床相关因素分析[J].中国中西医结合外科杂志2006, l(6):529
[3]吕立国,古炽明,王昭辉,代睿欣,潘明沃,范燕兰.陈志强教授对晚期前列腺癌中医病因病机的探讨[J].新中医,2007,39(2):81
[4]李曰庆主编,实用中西医结合泌尿男科学,第一版,北京:人民卫生出版社:186-190
[5]吴阶平马永江主编,实用泌尿外科学,第 1 版,北京:人民军医卫生出版社:258
[6]陈孝平主编,外科学,第 1 版,北京:人民卫生出版社:874-875
[7]仇成轩,施侣元,张惠娟.饮食与前列腺癌危险性关系的病例对照研究[J].中国慢性病预防与控制,2001, 9 (2) :75
[8]吴阶平马永江主编,实用泌尿外科学,第 1 版,北京:人民军医卫生出版社:259
[9]张惠娟,仇成轩,施侣元,刘小强,周宇凡.前列腺癌危险因素配比病例对照研究[ J].预防医学情报杂志,1999,15(1):9
[10]董志伟谷铣之主编,临床肿瘤学,第 1 版,北京:人民卫生出版社:1135-1149
[11]陈伟,李澄棣.治疗前列腺癌的中草药 PC-SPES[J].中华泌尿外科杂志,2002, 23( 6):378-379
[12] Small EJ, Frohl ich MW BokRet al. Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. [J] Clin Oncol, 2000, 18(21):3595
[13] Pirani JF.The effects of phytot herapeutic agents on prostate cancer:an overview of recent clinical trials of PC-SPES. Urology,2001,58(2suppl 1):36
[14]钟亮,赖海标,黄智峰,曾哗,赖伟业,伍伟超.中西医结合治疗晚期前列腺癌疗效观察[ J].现代中西医结合杂志,2005,14(4):480
[15]古炽明,吕立国,王昭辉,陈志强.中西医结合治疗前列腺癌的临床观察[J]. 广东药学院学报,2007,23(1):93
[16]张亚强,林 飞,刘猷枋.前列消癥汤治疗前列腺癌的临床观察[J] 中国中西医结合外科杂志,2006,12(2):83
[17]张秉鸿,,王庆堂,王 亮,南勋义.中药鸦胆子对前列腺癌细胞超微结构及 PSA水平的影响[J].西南国防医药,2007,17(4):402
[18]陈 铭,高松占,甄波.消瘀散结灌肠剂治疗晚期前列腺癌 18 例[J].甘肃中医,2007,20(7):42
[19] 吴自强. 中医外治学术研究近况[J].中医外治杂志,1992,2(3):40
[20]彭煜,培初.泉安方治疗晚期前列腺癌骨转移痛初探[J].中国男科学杂志,2004,18(4):47
[21]李广诚,曾江正. 补肾壮骨中药合博宁治疗骨转移癌 15 例[J].湖南中医杂志,2007,23(2):52
[22] 黄 立 中 , 莫 新 民 . 骨 转 移 瘤 的 中 医 病 机 认 识 与 治 疗 [J]. 湖 南 中 医 药 导报,1997,3(2-3):5
[23]刘临兰.阳和汤治疗骨转移疼痛 32 例.新中医,1994,(9):51
[24]黄立中,蒋益兰,曾松林,等.阳和汤加味治疗骨转移癌疼痛 63 例.湖南中医学院学报,1997,17(1):20
[25] 郑 翠 娥 , 王 晓 红 , 胡 晓 辉 . 阳 和 汤 加 减 治 疗 骨 肿 瘤 . 山 东 中 医 杂志,1998,17(2):62
[26]张剑.李辅仁治疗前列腺癌睾丸摘除术后诸症的经验[J].中医杂志,1998, 39( 2):83
[27]Hammar M Frisk J,Grimas
,et al. Acupuncture treatment of vasomotor symptoms in man with prostatic carcinoma: a pilot study.J Urol,1999, 161(3):853
[28]侯成饮,陈素嫣.扶正除湿饮治疗晚期前列腺癌 5 例疗效观察[J].山东中医杂志,1996, 15(增刊): 28
[29] Darzynkiew icz Z, Traganos F,Wu,JM,et al. Chinese herbal mixture PC-SPES in treatment of prostate cancer[J].Int J Oncol, 2000, 17: 729
[30]杜广,张正望,张永康,郭剑明. 中药制剂 PC-SPESⅡ对前列腺癌激素非依赖型细胞株 PC-3 诱导凋亡的作用[J]. 中华男科学杂志,2007,13(6):566
[31]Odakak,T Y.Indentification of antimicrobial and an tioxidant constitutes from licorice of Russia and X injiang origin[J].Chem Pham Bu[J]1987,37(9):25-28
[32]FujisawaY,SakamotoM,MatsushitaM,et lGlycyrrhizin inhibits the lytic pathway ofcomplement-possible mechanism of its anti-inflammatory effect on liver ells in viral hepatitis[J].Microbiolmmunol,2000,44 (9):799--804
[33] 王英俊,刘方州,侯勇谋.甘草甜素诱导前列腺癌细胞株 DU 145 凋亡的体外研究[J]. 中华男科学杂志,2007,4(11):146
[34]Ray KD,Mendulis LM,Gurule MW,et al Ca2+ antagonistsin- hib it DNA fragmentation and toxic cell death induced by acetam fragmentation and toxic cell death induced by acetam inophen[J]. FASE-BJ,1999, 7(5):453.
[35]Burlch W , Lauer B, T immermann -Trosier, et al Con trolled death apopto-sis) of nomal and putativepreneo plastic cells in rat liver following withdrawal of tumorprrmoters[J].Carcinogenesis, 2001, 5(4):5.
[36] 王小芹,杨静,郑航.异甘草素脂质体对人前列腺癌细胞体外增殖的抑制作用[J]. 医学新知杂志,2007,17(2):85
[37] 张瑞,张鹏宇,郭军,杨冬,王文杰,郑美华,马艳春.雷公藤内酯醇对小鼠前列腺癌细胞株 RM-1 的影响[J].中华男科学杂志,2007,13(3):237.
[38] 罗钰填,余建华,邓刚,叶章群.雷公藤内酯醇对前列腺癌细胞 P C- 3 及血管内皮生长因子的影响临床[J].泌尿外科杂志,2007,22(4):289
[39]郑敏,梅贤巨,鲍翠玉.大蒜多糖体体外抗柯萨奇病毒 B-3 作用[J]中国现代应用药学杂志,2005,22 (1): 4-6
[40]Agarwal C,Singh RP,Agarwal R G rape seed extract induces apoptotic death of human prostate carcinoma DL-145 cells viacaspases activation accompanied by dissipation of m itochondrial membrane potentia1 and cytochrom e c re lease[J].Carcinogenesis,2002,23 (11): 1869-76
[41]孙怡,商学军,葛京平,等.原花青素对前列腺癌 PC-3 细胞增殖和凋亡的影响[J].山东医药,2006,46(6): 12-4
[42]吴自勍，黄浩，丁雪梅，罗荣城.原花青素对前列腺癌 LNCaP 细胞增殖和凋亡的影响[J].南方医药大学学报,2007 ;27(4):499
[43]张维东,崔亚洲,武利存,等.蝎毒多肽提取物的抗血管生成作用[J].细胞生物学杂志,2005, 27( 3) : 343- 346
[44] 张月英,张维东,贾青,王兆朋,黄山英,宋守琴,王朝霞.蝎毒多肽提取物抑制 DU - 145 细胞,COX- 2 和 MMP- 9 表达的研究[J].现代生物医学进展,2006, 6 N0.5:10
[45] Ogasawara M, Matsubara T,Suzuki H. Screening of natural compounds for inhibitory activity on colon cancer cell migration [J].Biol Pham Bull,2001,24(6): 720-3.
[46]张莹,张起辉,吴立军,等.吴茱萸碱诱导人宫颈癌 Hela 细胞调亡过程中非caspase 调控因素[J].中国药理学通报,2004,20( 1): 61-4.
[47] 张辉,吕家驹,丁森泰,张捷,赵跃然.吴茱萸碱诱导前列腺癌 PC-3 细胞凋亡机制的实验研究[J].中国老年学杂志,2007,27:1231
[48]栾连军,王叶飞,张琳,吴永江.藤苦参素的体外抗肿瘤活性及其对癌细胞凋亡的作用[J].药学学报,2007, 42( 1): 104- 107
[49]丁新民,保庭毅,杨增悦,邱建新,巨生产.二氧化二砷对前列腺癌 PC -3 细胞周期调节分子的影响[J].医学研究生学报,2006,19(6):501
[50]Kinoshita H,Shi Y,Sandefur C,et al.Methylation receptor minimal promoter silences transcription in human prostate cancer [J].Cancer Res,2000,60(13):3623-3630
[51] 李小民.樊青霞.赵培荣.王瑞林.王留兴.三氧化二砷重新激活 PC- 3 前列腺癌细胞雄激素受体基因的表达.肿瘤基础与临床,2006,19(4):295
[52]厉将斌,王沛,那彦群,郭应禄.前列腺癌中医药治疗的经验与思路.中国中西医结合杂志,2002, 22(6):425 [51] 李小民.樊青霞.赵培荣.王瑞林.王留兴.三氧化二砷重新激活 PC- 3 前列腺癌细胞雄激素受体基因的表达.肿瘤基础与临床,2006,19(4):295 [52]厉将斌,王沛,那彦群,郭应禄.前列腺癌中医药治疗的经验与思路.中国中西